Publications

1. Cairat M, Rinaldi S, Navionis AS, Romieu I, Biessy C, Viallon V, et al. (2022). Circulating inflammatory biomarkers, adipokines and breast cancer risk – a case-control study nested within the EPIC cohort. BMC Med. 20(1):118. https//doi.org/10.1186/s12916-022-02319-y PMID:35430795
2. His M, Viallon V, Dossus L, Schmidt JA, Travis RC, Gunter MJ, et al. (2021). Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort. BMC Med. 19(1):312. https//doi.org/10.1186/s12916-021-02183-2 PMID:34886862
3. Dossus L, Kouloura E, Biessy C, Viallon V, Siskos AP, Dimou N, et al. (2021). Prospective analysis of circulating metabolites and endometrial cancer risk. Gynecol Oncol. 162(2):475–81. https//doi.org/10.1016/j.ygyno.2021.06.001 PMID:34099314
4. Karavasiloglou N, Hughes DJ, Murphy N, Schomburg L, Sun Q, Seher V, et al. (2023). Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts. Am J Clin Nutr. 117(1):33–45. https//doi.org/10.1016/j.ajcnut.2022.10.004 PMID:36789942
5. Wedekind R, Rothwell JA, Viallon V, Keski-Rahkonen P, Schmidt JA, Chajes V, et al. (2022). Determinants of blood acylcarnitine concentrations in healthy individuals of the European Prospective Investigation into Cancer and Nutrition. Clin Nutr. 41(8):1735–45. https//doi.org/10.1016/j.clnu.2022.05.020 PMID:35779425
6. Stepien M, Lopez-Nogueroles M, Lahoz A, Kühn T, Perlemuter G, Voican C, et al. (2022). Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma. Int J Cancer. 150(8):1255–68. https//doi.org/10.1002/ijc.33885 PMID:34843121
7. Mayén AL, Viallon V, Botteri E, Proust-Lima C, Bagnardi V, Batista V, et al. (2022). A longitudinal evaluation of alcohol intake throughout adulthood and colorectal cancer risk. Eur J Epidemiol. 37(9):915–29. https//doi.org/10.1007/s10654-022-00900-6 PMID:36063305
8. Breeur M, Ferrari P, Dossus L, Jenab M, Johansson M, Rinaldi S, et al. (2022). Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 20(1):351. https//doi.org/10.1186/s12916-022-02553-4 PMID:36258205
9. Botteri E, Peveri G, Berstad P, Bagnardi V, Chen SLF, Sandanger TM, et al. (2023). Changes in lifestyle and risk of colorectal cancer in the European Prospective Investigation Into Cancer and Nutrition. Am J Gastroenterol. 118(4):702–11. https//doi.org/10.14309/ajg.0000000000002065 PMID:36227801
10. Kliemann N, Rauber F, Bertazzi Levy R, Viallon V, Vamos EP, Cordova R, et al. (2023). Food processing and cancer risk in Europe: results from the prospective EPIC cohort study. Lancet Planet Health. 7(3):e219–32. https//doi.org/10.1016/S2542-5196(23)00021-9 PMID:36889863
11. Kliemann N, Al Nahas A, Vamos EP, Touvier M, Kesse-Guyot E, Gunter MJ, et al. (2022). Ultra-processed foods and cancer risk: from global food systems to individual exposures and mechanisms. Br J Cancer. 127(1):14–20. https//doi.org/10.1038/s41416-022-01749-y PMID:35236935
12. Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz BI, Huybrechts I (2022). Human microbiome and metabolic health: an overview of systematic reviews. Obes Rev. 23(4):e13409. https//doi.org/10.1111/obr.13409 PMID:34978141
13. Papadimitriou N, Bull CJ, Jenab M, Hughes DJ, Bell JA, Sanderson E, et al. (2023). Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. BMC Med. 21(1):5. https//doi.org/10.1186/s12916-022-02702-9 PMID:36600297
14. Murphy N, Newton CC, Song M, Papadimitriou N, Hoffmeister M, Phipps AI, et al. (2023). Body mass index and molecular subtypes of colorectal cancer. J Natl Cancer Inst. 115(2):165–73. https//doi.org/10.1093/jnci/djac215 PMID:36445035
15. Rothwell JA, Jenab M, Karimi M, Truong T, Mahamat-Saleh Y, Ferrari P, et al. (2022). Metabolic syndrome and risk of gastrointestinal cancers: an investigation using large-scale molecular data. Clin Gastroenterol Hepatol. 20(6):e1338–52. https//doi.org/10.1016/j.cgh.2021.10.016 PMID:34687971
16. Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, et al. (2022). Associations between glycemic traits and colorectal cancer: a Mendelian randomization analysis. J Natl Cancer Inst. 114(5):740–52. https//doi.org/10.1093/jnci/djac011 PMID:35048991
17. Sedlmeier AM, Viallon V, Ferrari P, Peruchet-Noray L, Fontvieille E, Amadou A, et al. (2023). Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study. Br J Cancer. 128(4):594–605. https//doi.org/10.1038/s41416-022-02071-3 PMID:36460776
18. Kohls M, Freisling H, Charvat H, Soerjomataram I, Viallon V, Davila-Batista V, et al. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1):546. https//doi.org/10.1186/s12885-022-09589-y PMID:35568802
19. Amadou A, Freisling H, Jenab M, Tsilidis KK, Trichopoulou A, Boffetta P, et al. (2021). Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium. Br J Cancer. 124(11):1882–90. https//doi.org/10.1038/s41416-021-01347-4 PMID:33772152
20. Recalde M, Davila-Batista V, Díaz Y, Leitzmann M, Romieu I, Freisling H, et al. (2021). Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain. BMC Med. 19(1):10. https//doi.org/10.1186/s12916-020-01877-3 PMID:33441148